Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines.
Agache I, Rocha C, Pereira A, Song Y, Alonso-Coello P, Solà I, Beltran J, Posso M, Akdis CA, Akdis M, Brockow K, Chivato T, Del Giacco S, Eiwegger T, Eyerich K, Giménez-Arnau A, Gutermuth J, Guttman-Yassky E, Maurer M, Ogg G, Ong P, O'Mahony L, Schwarze J, Werfel T, Canelo-Aybar C, Palomares O, Jutel M. Agache I, et al. Among authors: posso m. Allergy. 2021 Jan;76(1):59-70. doi: 10.1111/all.14547. Epub 2020 Sep 7. Allergy. 2021. PMID: 32767573
Clinical and histologic characteristics of breast cancers in women with previous pathologic diagnosis of benign breast disease in Spain.
Román M, Caicoya M, Espinàs J, Sala M, Torá-Rocamora I, Quinta MJ, Vernet M, Saladié F, Romero A, Sánchez M, Baré M, Vidal C, Servitja S, Natal C, Corominas J, Ferrer J, Rodríguez-Arana A, Castells X; BELE Project study group. Román M, et al. Breast J. 2018 Jul;24(4):509-518. doi: 10.1111/tbj.13003. Epub 2018 Mar 8. Breast J. 2018. PMID: 29517151
Methodological systematic review identifies major limitations in prioritization processes for updating.
Martínez García L, Pardo-Hernandez H, Superchi C, Niño de Guzman E, Ballesteros M, Ibargoyen Roteta N, McFarlane E, Posso M, Roqué I Figuls M, Rotaeche Del Campo R, Sanabria AJ, Selva A, Solà I, Vernooij RWM, Alonso-Coello P. Martínez García L, et al. Among authors: posso m. J Clin Epidemiol. 2017 Jun;86:11-24. doi: 10.1016/j.jclinepi.2017.05.008. Epub 2017 May 24. J Clin Epidemiol. 2017. PMID: 28549931 Review.
Development of a prioritisation tool for the updating of clinical guideline questions: the UpPriority Tool protocol.
Martínez García L, Pardo-Hernandez H, Niño de Guzman E, Superchi C, Ballesteros M, McFarlane E, Penman K, Posso M, Roqué I Figuls M, Sanabria AJ, Selva A, Vernooij RW, Alonso-Coello P. Martínez García L, et al. Among authors: posso m. BMJ Open. 2017 Aug 3;7(8):e017226. doi: 10.1136/bmjopen-2017-017226. BMJ Open. 2017. PMID: 28775194 Free PMC article.
Intensive follow-up for women with breast cancer: review of clinical, economic and patient's preference domains through evidence to decision framework.
Lafranconi A, Pylkkänen L, Deandrea S, Bramesfeld A, Lerda D, Neamțiu L, Saz-Parkinson Z, Posso M, Rigau D, Sola I, Alonso-Coello P, Martinez-Zapata MJ. Lafranconi A, et al. Among authors: posso m. Health Qual Life Outcomes. 2017 Oct 19;15(1):206. doi: 10.1186/s12955-017-0779-5. Health Qual Life Outcomes. 2017. PMID: 29052503 Free PMC article. Review.
Methods for Development of the European Commission Initiative on Breast Cancer Guidelines: Recommendations in the Era of Guideline Transparency.
Schünemann HJ, Lerda D, Dimitrova N, Alonso-Coello P, Gräwingholt A, Quinn C, Follmann M, Mansel R, Sardanelli F, Rossi PG, Lebeau A, Nyström L, Broeders M, Ioannidou-Mouzaka L, Duffy SW, Borisch B, Fitzpatrick P, Hofvind S, Castells X, Giordano L, Warman S, Saz-Parkinson Z; European Commission Initiative on Breast Cancer Contributor Group. Schünemann HJ, et al. Ann Intern Med. 2019 Aug 20;171(4):273-280. doi: 10.7326/M18-3445. Epub 2019 Jul 23. Ann Intern Med. 2019. PMID: 31330534
Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines.
Schünemann HJ, Lerda D, Quinn C, Follmann M, Alonso-Coello P, Rossi PG, Lebeau A, Nyström L, Broeders M, Ioannidou-Mouzaka L, Duffy SW, Borisch B, Fitzpatrick P, Hofvind S, Castells X, Giordano L, Canelo-Aybar C, Warman S, Mansel R, Sardanelli F, Parmelli E, Gräwingholt A, Saz-Parkinson Z; European Commission Initiative on Breast Cancer (ECIBC) Contributor Group. Schünemann HJ, et al. Ann Intern Med. 2020 Jan 7;172(1):46-56. doi: 10.7326/M19-2125. Epub 2019 Nov 26. Ann Intern Med. 2020. PMID: 31766052 Free article.
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.
Agache I, Beltran J, Akdis C, Akdis M, Canelo-Aybar C, Canonica GW, Casale T, Chivato T, Corren J, Del Giacco S, Eiwegger T, Firinu D, Gern JE, Hamelmann E, Hanania N, Mäkelä M, Hernández-Martín I, Nair P, O'Mahony L, Papadopoulos NG, Papi A, Park HS, Pérez de Llano L, Posso M, Rocha C, Quirce S, Sastre J, Shamji M, Song Y, Steiner C, Schwarze J, Alonso-Coello P, Palomares O, Jutel M. Agache I, et al. Among authors: posso m. Allergy. 2020 May;75(5):1023-1042. doi: 10.1111/all.14221. Epub 2020 Feb 24. Allergy. 2020. PMID: 32034960
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.
Agache I, Rocha C, Beltran J, Song Y, Posso M, Solà I, Alonso-Coello P, Akdis C, Akdis M, Canonica GW, Casale T, Chivato T, Corren J, Del Giacco S, Eiwegger T, Firinu D, Gern JE, Hamelmann E, Hanania N, Mäkelä M, Martín IH, Nair P, O'Mahony L, Papadopoulos NG, Papi A, Park HS, Pérez de Llano L, Quirce S, Sastre J, Shamji M, Schwarze J, Canelo-Aybar C, Palomares O, Jutel M. Agache I, et al. Among authors: posso m. Allergy. 2020 May;75(5):1043-1057. doi: 10.1111/all.14235. Allergy. 2020. PMID: 32064642
94 results